Literature DB >> 15170192

PET concerns in bevacizumab treatment.

Carsten Goessl, Zarko Grozdanovic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170192     DOI: 10.1038/nm0604-561a

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

Review 1.  Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.

Authors:  Dan G Duda; Rakesh K Jain; Christopher G Willett
Journal:  J Clin Oncol       Date:  2007-09-10       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.